PHAS
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
PHAS
Delisted
PHAS was delisted on the 2nd of November, 2022.
5 hedge funds and large institutions have $15.6K invested in PhaseBio Pharmaceuticals, Inc. Common Stock in 2022 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 34 closing their positions.
New
Increased
Maintained
Reduced
Closed
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less capital invested
Capital invested by funds: $ → $
Holders
5
Holding in Top 10
–
Calls
–
Puts
–
Top Sellers
| 1 | -$1.17M | |
| 2 | -$768K | |
| 3 | -$479K | |
| 4 |
MCM
MAI Capital Management
Independence,
Ohio
|
-$406K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$318K |
